Testing effectiveness (Phase 2)Ended earlyNCT02664961
What this trial is testing
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Who this might be right for
Gestational Trophoblastic NeoplasiaChoriocarcinomaPlacental Site Trophoblastic Tumor+1 more
Tracon Pharmaceuticals Inc. 3